These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2924921)

  • 21. Reversible covalent binding of peptide nitriles to papain.
    Hanzlik RP; Zygmunt J; Moon JB
    Biochim Biophys Acta; 1990 Jul; 1035(1):62-70. PubMed ID: 2383580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of signalling and non-signalling binding contributions to enzyme reactivity. Alternative combinations of binding interactions provide for change in transition-state geometry in reactions of papain.
    Kowlessur D; Topham CM; Thomas EW; O'Driscoll M; Templeton W; Brocklehurst K
    Biochem J; 1989 Mar; 258(3):755-64. PubMed ID: 2730566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E-64c-hydrazide: a lead structure for the development of irreversible cathepsin C inhibitors.
    Radzey H; Rethmeier M; Klimpel D; Grundhuber M; Sommerhoff CP; Schaschke N
    ChemMedChem; 2013 Aug; 8(8):1314-21. PubMed ID: 23780739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis. Structural analysis, subtilisin structure and interface geometry.
    Bode W; Papamokos E; Musil D
    Eur J Biochem; 1987 Aug; 166(3):673-92. PubMed ID: 3301348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A kinetic study of hydrophobic interactions at the S1 and S2 sites of papain.
    Brubacher LJ; Zaher MR
    Can J Biochem; 1979 Aug; 57(8):1064-72. PubMed ID: 44219
    [No Abstract]   [Full Text] [Related]  

  • 26. Dependence of the P2-S2 stereochemical selectivity of papain on the nature of the catalytic-site chemistry. Quantification of selectivity in the catalysed hydrolysis of the enantiomeric N-acetylphenylalanylglycine 4-nitroanilides.
    Kowlessur D; Thomas EW; Topham CM; Templeton W; Brocklehurst K
    Biochem J; 1990 Mar; 266(3):653-60. PubMed ID: 2327954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clarification of substrate specificity of papain by crystal analyses of complexes with covalent-type inhibitors.
    Matsumoto K; Murata M; Sumiya S; Kitamura K; Ishida T
    Biochim Biophys Acta; 1994 Oct; 1208(2):268-76. PubMed ID: 7947958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of crystallography, graphics, and quantitative structure--activity relationships in the analysis of the papain hydrolysis of X-phenyl hippurates.
    Smith RN; Hansch C; Kim KH; Omiya B; Fukumura G; Selassie CD; Jow PY; Blaney JM; Langridge R
    Arch Biochem Biophys; 1982 Apr; 215(1):319-28. PubMed ID: 7092233
    [No Abstract]   [Full Text] [Related]  

  • 29. Benzoylamidoacetonitrile is bound as a thioimidate in the active site of papain.
    Brisson JR; Carey PR; Storer AC
    J Biol Chem; 1986 Jul; 261(20):9087-9. PubMed ID: 3722189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor.
    Swain AL; Miller MM; Green J; Rich DH; Schneider J; Kent SB; Wlodawer A
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8805-9. PubMed ID: 2247451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling family 2 cystatins and their interaction with papain.
    Nandy SK; Bhuyan R; Seal A
    J Biomol Struct Dyn; 2013; 31(6):649-64. PubMed ID: 22881286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standardization of papain reagents by measurement of active sites using a synthetic inhibitor, E-64.
    Scott ML; Whitton CM
    Transfusion; 1988; 28(1):24-8. PubMed ID: 3341061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal and molecular structure of the sulfhydryl protease calotropin DI at 3.2 A resolution.
    Heinemann U; Pal GP; Hilgenfeld R; Saenger W
    J Mol Biol; 1982 Nov; 161(4):591-606. PubMed ID: 6759664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ionization characteristics of the Cys-25/His-159 interactive system and of the modulatory group of papain: resolution of ambiguity by electronic perturbation of the quasi-2-mercaptopyridine leaving group in a new pyrimidyl disulphide reactivity probe.
    Mellor GW; Thomas EW; Topham CM; Brocklehurst K
    Biochem J; 1993 Feb; 290 ( Pt 1)(Pt 1):289-96. PubMed ID: 8439297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of inhibition of cathepsin K by potent, selective 1, 5-diacylcarbohydrazides: a new class of mechanism-based inhibitors of thiol proteases.
    Bossard MJ; Tomaszek TA; Levy MA; Ijames CF; Huddleston MJ; Briand J; Thompson S; Halpert S; Veber DF; Carr SA; Meek TD; Tew DG
    Biochemistry; 1999 Nov; 38(48):15893-902. PubMed ID: 10625455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Papain inhibitions by optically active E-64 analogs.
    Tamai M; Hanada K; Adachi T; Oguma K; Kashiwagi K; Omura S; Ohzeki M
    J Biochem; 1981 Jul; 90(1):255-7. PubMed ID: 7287681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structure of the parasite inhibitor chagasin in complex with papain allows identification of structural requirements for broad reactivity and specificity determinants for target proteases.
    Redzynia I; Ljunggren A; Bujacz A; Abrahamson M; Jaskolski M; Bujacz G
    FEBS J; 2009 Feb; 276(3):793-806. PubMed ID: 19143838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solution structure of a human cystatin A variant, cystatin A2-98 M65L, by NMR spectroscopy. A possible role of the interactions between the N- and C-termini to maintain the inhibitory active form of cystatin A.
    Tate S; Ushioda T; Utsunomiya-Tate N; Shibuya K; Ohyama Y; Nakano Y; Kaji H; Inagaki F; Samejima T; Kainosho M
    Biochemistry; 1995 Nov; 34(45):14637-48. PubMed ID: 7578072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of hydroxyl group and R/S configuration of isostere in binding properties of HIV-1 protease inhibitors.
    Petroková H; Dusková J; Dohnálek J; Skálová T; Vondrácková-Buchtelová E; Soucek M; Konvalinka J; Brynda J; Fábry M; Sedlácek J; Hasek J
    Eur J Biochem; 2004 Nov; 271(22):4451-61. PubMed ID: 15560786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of thioredoxin from Escherichia coli at 1.68 A resolution.
    Katti SK; LeMaster DM; Eklund H
    J Mol Biol; 1990 Mar; 212(1):167-84. PubMed ID: 2181145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.